Anadys

About:

Anadys Pharmaceuticals, a biopharmaceutical company, develops medicines for the treatment of hepatitis C.

Website: http://www.anadyspharma.com

Description:

Anadys Pharmaceuticals is a biopharmaceutical company dedicated to developing medicines for the treatment of hepatitis C. The company is developing ANA598, a non-nucleoside polymerase inhibitor for the treatment of hepatitis C. Anadys has also investigated the potential of ANA773, an oral, small-molecule inducer of endogenous interferons that acts via the Toll-like receptor 7, or TLR7, pathway in hepatitis C.

Total Funding Amount:

$17.5M

Headquarters Location:

San Diego, California, United States

Founded Date:

2000-01-01

Founders:

Number of Employees:

11-50

Last Funding Date:

2009-06-04

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai